The Pharmaceutical Science Team at DIT actively engages with global industry and regulators to address the challenges and opportunities of implementing Science and Risk based manufacturing approaches. Their research emphasis is on the development of patient-focused strategies to enable those involved in the manufacture of drug products to meet evolving international regulatory expectations, those interested in embarking in an MSc or Doctorate program in this area, please visit the website.